| abstract |
Pharmaceutical compositions containing Vitamin D receptor activators or Vitamin D analogs for treating, preventing or inhibiting vascular diseases, among other conditions, are described. Pharmaceutical compositions may also include ACE inhibitors or other agents. Methods for reducing the expression of PAI-1 are also described by administering effective amounts of Vitamin D receptor activators or Vitamin D analogs to a mammal in need thereof. Methods are also described for preventing, inhibiting or treating thrombosis in a mammal with the need for such prevention, inhibition or treatment comprising administering effective amounts of Vitamin D receptor activators or Vitamin D analogs to the mammal. |